SMS Pharmaceuticals Ltd

NSE
SMSPHARMA •
BUY

1W Return

-%

1M Return

-%

6M Return

-%

1Y Return

-%

3Y Return

-%

Start SIP in SMS Pharmaceuticals Ltd
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
New 52W High in past week
28.4
TTM PE Ratio
Above industry Median
33.2
Price to Book Ratio
Below industry Median
2.8
Dividend yield 1yr %
Low in industry
0.2
TTM PEG Ratio
0
RSI
RSI is mid-range
62.4
MFI
MFI Overbought
70.1

SMS Pharmaceuticals Ltd Key Financials

*All values are in ₹ Cr.

SMS Pharmaceuticals Ltd shareholding Pattern

Promoter
64.3%
Foreign Institutions
0.6%
Public
35.1%

SMS Pharmaceuticals Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
16
Bearish Moving Averages
0
5Day EMA
150.10
10Day EMA
148.70
12Day EMA
148.00
20Day EMA
144.90
26Day EMA
142.80
50Day EMA
136.60
100Day EMA
129.30
200Day EMA
119.20
Delivery & Volume
Resistance & Support
151.32
Pivot
Resistance
First Resistance
155.53
Second Resistance
158.82
Third Resistance
163.03
Support
First Support
148.03
Second support
143.82
Third Support
140.53
Relative Strength Index
62.42
Money Flow Index
70.13
MACD
5.21
MACD Signal
5.35
Average True Range
7.32
Average Directional Index
39.67
Rate of Change (21)
16.80
Rate of Change (125)
18.39

SMS Pharmaceuticals Ltd Company background

Founded in: 1987
Managing director: P Ramesh Babu
SMS Pharmaceuticals Limited is a Public company incorporated in December 14, 1987. The company is engaged in the business of manufacturing of Active Pharma Ingredients and their intermediates. Apart from R D Center at Gagillapur, Hyderabad, the company is having manufacturing facilities at Bachupally, Hyderabad and also at Kandivalasa in Vijayanagaram Dist. Its business activity is a single primary business segment of Bulk Drugs. During the year 2015, the company has reenforced its fundamental strength of FDA compliant facilities by successfully completing the US FDA audits at Kandivalasa and Bachupally facilities.During the year 2015, the company filed 9 Drug Master Files and total DMFs filed up to 31 March 2015 are 24.During the year 201415, the Company acquired 12,25,900 equity shares of Rs. 10/ each in M/s. VKT Pharma Private Limited. With this the said company has become an associate company. The project of the said associate company is in final stage and at the verge of completion and operations are yet to be commenced. The Company has not having any subsidiaries.During the year 201516, the Company had sub divided the face value of share of Rs 10/ each into face value of Rs 1/ of each with record date of 18th December 2015.During FY 201516, the Board has approved the Draft Scheme of Arrangement for Demerger of Semi Regulated Units (Unit I, IV V) along with other Assets to transfer the same to SMS Lifesciences India Limited (Resulting Company), with an object to reduce the impact of Semi Regulated Units on Regulated Units, achieving operational efficiencies, site synergies and streamlining its current structure. The Draft Scheme of Arrangement is subject to the Approvals of Stock Exchanges, Securities Board of India Limited, Reserve Bank of India and other regulatory authorities and also Honble High Court of Judicature at Hyderabad for the State of Telangana and Andhra Pradesh.During FY 201617, the Company had made investment in its associate Company viz. M/s. VKT Pharma Private Limited for its business purpose. During the year under review 201617, the Company had acquired 5,11,400 equity shares of face value of Rs 10/ each in the said associate at an average price of Rs 157.21. Further, the Company had also made an investment in 1000 equity shares of Sireen Drugs Private Limited of Rs 10/ each.SMS Lifesciences India Limited is the wholly owned subsidiary of the Company during the Financial Year 201617.In FY 201718, the Scheme of arrangement between SMS Pharmaceuticals Limited (Demerged Company) with SMS Lifesciences India Limited (Resulting Company) and their respective Shareholders and Creditors provides for the demerger of the Semi Regulated Units No. I, IV and V along with premises situated at Industrial Estate, Santhnagar, Hyderabad Industrial Development Area, Jeedimetla, Hyderabad Premises bearing Flat No.417, Nilgiri, Aditya Enclave, Ameerpet, Hyderabad vacant land admeasuring Ac 19 cents situated at Pharma City, Parawada, Visakhapatnam and Investments relating to Semi Regulated Units (Demerged Undertaking) of SMS Pharmaceuticals Limited, the Demerged Company into SMS Lifesciences India Limited, the Resulting Company as specified in the scheme. The scheme was approved by the Honble National Company Law Tribunal, Hyderabad Bench vide its Order No. C.P (CAA) No.7/230/232/HDB/2017 dated 15th May 2017. The effective date of the Scheme is 17th May 2017. SMS Lifesciences India Limited (Resulting Company) in accordance with the approved Scheme of Arrangement has allotted 30,23,287 equity shares of Rs.10/ each to the shareholders of the company by fixing Record Date as on 23rd June, 2017. Pursuant to approved Scheme, the Resulting Company shares will be listed on Stock Exchanges viz., BSE NSE where the equity shares of SMS Pharmaceuticals Limited are listed.The Company had made investment in its associate company viz. M/s. VKT Pharma Private Limited for its business purpose. During the year under review 201718, the Company had acquired 7,84,100 equity shares of face value of Rs.10/ each in the said associate at an average price of Rs.200.81.During FY 201819, the Company had made investment in its associate Company viz. M/s. VKT Pharma Private Limited for its business purpose. The Company held 38,50,165 equity shares of Rs 10/ each in VKT Pharma Private Limited as on 31st March 2019 as investments.
Read More

SMS Pharmaceuticals Ltd FAQs

SMS Pharmaceuticals Ltd shares are currently priced at 152.25 on NSE and 151.95 on BSE as of 3/1/2024 12:00:00 AM. Please be aware that stock prices are subject to continuous fluctuations due to various factors.

The past 1-year return of SMS Pharmaceuticals Ltd [SMSPHARMA] share was 120.33. The SMS Pharmaceuticals Ltd [SMSPHARMA] share hit a 1-year low of Rs. 54.55 and a 1-year high of Rs. 161.45.

The market cap of SMS Pharmaceuticals Ltd is Rs. 1288.83 Cr. as of 3/1/2024 12:00:00 AM.

The PE ratios of SMS Pharmaceuticals Ltd is 30.95 as of 3/1/2024 12:00:00 AM.

The PB ratios of SMS Pharmaceuticals Ltd is 2.5 as of 3/1/2024 12:00:00 AM

You can easily buy SMS Pharmaceuticals Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
or Resume your Application
+91 -

personImage